A key component of blueberries, 3,5-dimethoxy-4-hydroxystilbene, inhibits breast cancer stem cells through the down-regulation of epithelial to mesenchymal transition, the down-regulation of NF-κB, and decreased levels of tumor-associated macrophages (TAMs). Here, NFKB1 is linked to breast carcinoma.